Time’s imprint on the left atrium: aging and atrial myopathy

Abstract

Aging is a primary driver of atrial remodeling and dysfunction, and contributes to the increasing prevalence of atrial myopathy in the aging population. Atrial myopathy, characterized by structural, functional, and electrophysiological abnormalities of the atria, is a key pathological process underlying adverse cardiovascular outcomes such as atrial fibrillation (AF), heart failure with preserved ejection fraction (HFpEF), and ischemic stroke. Although these outcomes are often treated as distinct clinical entities, emerging evidence suggests that they may represent symptomatic manifestations of an underlying atrial disease process. Aging promotes atrial myopathy through multiple mechanisms, including inflammation, extracellular matrix remodeling, electrophysiological alterations, cellular senescence, epigenetic modifications, and non-coding RNA regulation. These changes collectively lead to atrial fibrosis, impaired mechanical function, conduction abnormalities, and a prothrombotic state. Despite its clinical significance, atrial myopathy remains an underrecognized entity, with current management strategies primarily focusing on treating its downstream complications rather than the underlying disease. Advances in imaging techniques, biomarker discovery, and molecular research have the potential to improve the early detection and risk stratification of atrial myopathy, paving the way for novel therapeutic strategies. In this review, we discuss the structural, mechanical, electrophysiological, and metabolic changes that occur in the aging atrium, explore the cellular and molecular mechanisms that drive these changes, and highlight recent advances in diagnostic and therapeutic approaches. By shifting the focus from managing AF and HFpEF to targeting the underlying atrial myopathy, we can unlock new avenues for prevention and treatment, ultimately improving cardiovascular health in the aging population.

Keywords

Atrial fibrillation / atrial myopathy / left atrial reservoir strain / senescence

References

[1] World Health Organization. Global strategy and action plan on ageing and health. 2017. Available from: https://www.who.int/publications/i/item/global-strategy-and-action-plan-on-ageing-and-health [Last accessed on 18 Mar 2025]

[2] Linz D,Betz K.Atrial fibrillation: epidemiology, screening and digital health.Lancet Reg Health Eur2024;37:100786 PMCID:PMC10866942

[3] Borlaug BA,Shah SJ.Heart failure with preserved ejection fraction: JACC scientific statement.J Am Coll Cardiol2023;81:1810-34

[4] Fauchier L,Bodin A.Heart failure with preserved ejection fraction and atrial fibrillation: recent advances and open questions.BMC Med2023;21:54 PMCID:PMC9926737

[5] Goette A,Aguinaga L.EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication.Heart Rhythm2017;14:e3-40 PMCID:PMC5548137

[6] Goldberger JJ,Green D.Evaluating the atrial myopathy underlying atrial fibrillation: identifying the arrhythmogenic and thrombogenic substrate.Circulation2015;132:278-91 PMCID:PMC4520257

[7] Omote K.Left atrial myopathy in heart failure with preserved ejection fraction.Circ J2023;87:1039-46

[8] Shen MJ,Jalife J.Atrial myopathy.JACC Basic Transl Sci2019;4:640-54 PMCID:PMC6872845

[9] Inciardi RM,Minamisawa M.Association of left atrial structure and function with heart failure in older adults.J Am Coll Cardiol2022;79:1549-61

[10] Inciardi RM,Alonso A.Cardiac mechanics and the risk of atrial fibrillation in a community-based cohort of older adults.Eur Heart J Cardiovasc Imaging2024;25:1686-94

[11] Maheshwari A,Inciardi RM.Left atrial mechanical dysfunction and the risk for ischemic stroke in people without prevalent atrial fibrillation or stroke: a prospective cohort study.Ann Intern Med2023;176:39-48 PMCID:PMC11793084

[12] Wang W,Inciardi RM.Association of echocardiographic measures of left atrial function and size with incident dementia.JAMA2022;327:1138-48 PMCID:PMC8941355

[13] Lamberts RR,Wang HY.Impaired relaxation despite upregulated calcium-handling protein atrial myocardium from type 2 diabetic patients with preserved ejection fraction.Cardiovasc Diabetol2014;13:72 PMCID:PMC3997226

[14] Watanabe M,Mitsuyama H,Ono T.Conduction and refractory disorders in the diabetic atrium.Am J Physiol Heart Circ Physiol2012;303:H86-95

[15] Kato T,Sekiguchi A.AGEs-RAGE system mediates atrial structural remodeling in the diabetic rat.J Cardiovasc Electrophysiol2008;19:415-20

[16] Goette A,Kuchenbecker A.Cigarette smoking induces atrial fibrosis in humans via nicotine.Heart2007;93:1056-63 PMCID:PMC1955003

[17] Xu TY,Lee AP.Left atrial function as assessed by speckle-tracking echocardiography in hypertension.Medicine2015;94:e526 PMCID:PMC4602743

[18] Disertori M,Grasso M.Autosomal recessive atrial dilated cardiomyopathy with standstill evolution associated with mutation of Natriuretic Peptide Precursor A.Circ Cardiovasc Genet2013;6:27-36

[19] Peng W,Li H.Dysfunction of myosin light-chain 4 (MYL4) leads to heritable atrial cardiomyopathy with electrical, contractile, and structural components: evidence from genetically-engineered rats.J Am Heart Assoc2017;6:e007030 PMCID:PMC5721782

[20] Zhu Y,Zheng B.Genetic findings in patients with primary fibrotic atrial cardiomyopathy.Eur J Med Genet2022;65:104429

[21] Vergaro G,Rapezzi C.Atrial amyloidosis: mechanisms and clinical manifestations.Eur J Heart Fail2022;24:2019-28 PMCID:PMC10087817

[22] Nochioka K,Claggett B.Left atrial structure and function in cardiac amyloidosis.Eur Heart J Cardiovasc Imaging2017;18:1128-37

[23] Bandera F,Chacko L.Clinical importance of left atrial infiltration in cardiac transthyretin amyloidosis.JACC Cardiovasc Imaging2022;15:17-29 PMCID:PMC8724534

[24] Sanchis K,Colombat M.Atrial fibrillation and subtype of atrial fibrillation in cardiac amyloidosis: clinical and echocardiographic features, impact on mortality.Amyloid2019;26:128-38

[25] Feng D,Martinez M.Intracardiac thrombosis and anticoagulation therapy in cardiac amyloidosis.Circulation2009;119:2490-7

[26] Dubrey S,Skinner M.Atrial thrombi occurring during sinus rhythm in cardiac amyloidosis: evidence for atrial electromechanical dissociation.Br Heart J1995;74:541-4 PMCID:PMC484078

[27] El-Am EA,Melduni RM.Direct current cardioversion of atrial arrhythmias in adults with cardiac amyloidosis.J Am Coll Cardiol2019;73:589-97 PMCID:PMC6378685

[28] Feng D,Oh JK.Intracardiac thrombosis and embolism in patients with cardiac amyloidosis.Circulation2007;116:2420-6

[29] Cappelli F,Russo D.Arterial thrombo-embolic events in cardiac amyloidosis: a look beyond atrial fibrillation.Amyloid2021;28:12-8

[30] Singh A,Miyoshi T.Normal values of left atrial size and function and the impact of age: results of the world alliance societies of echocardiography study.J Am Soc Echocardiogr2022;35:154-64.e3

[31] Medrano G,Pham T.Left atrial volume and pulmonary artery diameter are noninvasive measures of age-related diastolic dysfunction in mice.J Gerontol A Biol Sci Med Sci2016;71:1141-50 PMCID:PMC6080426

[32] Pan NH,Chang NC,Chen SA.Aging dilates atrium and pulmonary veins: implications for the genesis of atrial fibrillation.Chest2008;133:190-6

[33] Eshoo S,Thomas L.Impact of mild hypertension on left atrial size and function.Circ Cardiovasc Imaging2009;2:93-9

[34] Pritchett AM,Jacobsen SJ,Karon BL.Diastolic dysfunction and left atrial volume: a population-based study.J Am Coll Cardiol2005;45:87-92

[35] Lin KB,Li S.Impaired left atrial performance resulting from age-related arial fibrillation is associated with increased fibrosis burden: insights from a clinical study combining with an in vivo experiment.Front Cardiovasc Med2020;7:615065 PMCID:PMC7901954

[36] Gramley F,Knackstedt C.Age-related atrial fibrosis.AGE2009;31:27-38 PMCID:PMC2645993

[37] Jansen HJ,Rafferty SA.Atrial fibrillation in aging and frail mice: modulation by natriuretic peptide receptor C.Circ Arrhythm Electrophysiol2021;14:e010077

[38] Takahashi Y,Otsubo T.Histological validation of atrial structural remodelling in patients with atrial fibrillation.Eur Heart J2023;44:3339-53 PMCID:PMC10499545

[39] Clarke JD,Pearman CM,Trafford AW.Increased Ca buffering underpins remodelling of Ca²⁺ handling in old sheep atrial myocytes.J Physiol2017;595:6263-79 PMCID:PMC5621500

[40] Hayashi H,Miyauchi Y.Aging-related increase to inducible atrial fibrillation in the rat model.J Cardiovasc Electrophysiol2002;13:801-8

[41] Wu L,van Wezenbeek J.Atrial inflammation in different atrial fibrillation subtypes and its relation with clinical risk factors.Clin Res Cardiol2020;109:1271-81 PMCID:PMC7515944

[42] Tan R,Wang L.The pathogenesis of aging-induced left atrial appendage thrombus formation and cardioembolic stroke in mice is influenced by inflammation-derived matrix metalloproteinases.Thromb Res2023;226:69-81

[43] Wehrum T,Hagenlocher P.Age-related changes of right atrial morphology and inflow pattern assessed using 4D flow cardiovascular magnetic resonance: results of a population-based study.J Cardiovasc Magn Reson2018;20:38 PMCID:PMC6001162

[44] Jansen HJ,Mackasey M.Atrial structure, function and arrhythmogenesis in aged and frail mice.Sci Rep2017;7:44336 PMCID:PMC5349540

[45] Hoit BD.Left atrial size and function: role in prognosis.J Am Coll Cardiol2014;63:493-505

[46] Sugimoto T,Dulgheru R.Echocardiographic reference ranges for normal left atrial function parameters: results from the EACVI NORRE study.Eur Heart J Cardiovasc Imaging2018;19:630-8

[47] Nyberg J,Østvik A.Echocardiographic reference ranges of global longitudinal strain for all cardiac chambers using guideline-directed dedicated views.JACC Cardiovasc Imaging2023;16:1516-31

[48] Zhang MJ,Healy CL.Atrial myopathy quantified by speckle-tracking echocardiography in mice.Circ Cardiovasc Imaging2023;16:e015735 PMCID:PMC10591948

[49] Abou R,Tonsbeek AM.Effect of aging on left atrial compliance and electromechanical properties in subjects without structural heart disease.Am J Cardiol2017;120:140-7

[50] Liao JN,Kuo JY.Age, sex, and blood pressure-related influences on reference values of left atrial deformation and mechanics from a large-scale Asian population.Circ Cardiovasc Imaging2017;10:e006077

[51] Boyd AC,Leung D,Thomas L.Atrial dilation and altered function are mediated by age and diastolic function but not before the eighth decade.JACC Cardiovasc Imaging2011;4:234-42

[52] Chen LY,Platonov PG.P wave parameters and indices: a critical appraisal of clinical utility, challenges, and future research-a consensus document endorsed by the international society of electrocardiology and the international society for holter and noninvasive electrocardiology.Circ Arrhythm Electrophysiol2022;15:e010435

[53] Eranti A,Kerola T.Prevalence and prognostic significance of abnormal P terminal force in lead V1 of the ECG in the general population.Circ Arrhythm Electrophysiol2014;7:1116-21

[54] Wolder LD,Baadsgaard KH.Electrocardiographic P terminal force in lead V1, its components, and the association with stroke and atrial fibrillation or flutter.Heart Rhythm2023;20:354-62

[55] Turhan H,Sahin O.Comparison of P-wave duration and dispersion in patients aged > 65 years with those aged < 45 years.J Electrocardiol2003;36:321-6

[56] Magnani JW,Sullivan LM.P wave duration and risk of longitudinal atrial fibrillation in persons ≥ 60 years old (from the Framingham Heart Study).Am J Cardiol2011;107:917-21.e1 PMCID:PMC3049849

[57] Soliman EZ,Case LD,Goff DC Jr.Ethnic distribution of ECG predictors of atrial fibrillation and its impact on understanding the ethnic distribution of ischemic stroke in the Atherosclerosis Risk in Communities (ARIC) study.Stroke2009;40:1204-11 PMCID:PMC2685189

[58] Achmad C,Akbar MR.Left volume atrial index and P-wave dispersion as predictors of postoperative atrial fibrillation after coronary artery bypass graft: a retrospective cohort study.Curr Probl Cardiol2023;48:101031

[59] Materazzo C,Mantovani C,Villani F.Atrial fibrillation after non-cardiac surgery: P-wave characteristics and Holter monitoring in risk assessment.Eur J Cardiothorac Surg2007;31:812-6

[60] van der Does WFB,Heida A.Atrial electrophysiological characteristics of aging.J Cardiovasc Electrophysiol2021;32:903-12 PMCID:PMC8048566

[61] Kistler PM,Fynn SP.Electrophysiologic and electroanatomic changes in the human atrium associated with age.J Am Coll Cardiol2004;44:109-16

[62] Sim I,O'Neill M.Left atrial voltage mapping: defining and targeting the atrial fibrillation substrate.J Interv Card Electrophysiol2019;56:213-27 PMCID:PMC6900285

[63] Ahmed-Jushuf F,Dhillon P.The impact of the presence of left atrial low voltage areas on outcomes from pulmonary vein isolation.J Arrhythm2019;35:205-14 PMCID:PMC6457382

[64] Yamaguchi T,Takahashi Y.Atrial structural remodeling in patients with atrial fibrillation is a diffuse fibrotic process: evidence from high-density voltage mapping and atrial biopsy.J Am Heart Assoc2022;11:e024521 PMCID:PMC9075313

[65] Emelyanova L,Gupta A.Effect of aging on mitochondrial energetics in the human atria.J Gerontol A Biol Sci Med Sci2018;73:608-16 PMCID:PMC5905598

[66] Nemutlu E,Zhang S.Decline of phosphotransfer and substrate supply metabolic circuits hinders ATP cycling in aging myocardium.PLoS One2015;10:e0136556 PMCID:PMC4574965

[67] Lee HC,Jhuo SJ.The sodium-glucose co-transporter 2 inhibitor empagliflozin attenuates cardiac fibrosis and improves ventricular hemodynamics in hypertensive heart failure rats.Cardiovasc Diabetol2019;18:45 PMCID:PMC6444638

[68] Franceschi C,Monti D.Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans.Mech Ageing Dev2007;128:92-105

[69] Thomas TP.The dynamic interplay between cardiac inflammation and fibrosis.Front Physiol2020;11:529075 PMCID:PMC7522448

[70] Mesquita TRR,de Couto G.Mechanisms of atrial fibrillation in aged rats with heart failure with preserved ejection fraction.Heart Rhythm2020;17:1025-33 PMCID:PMC7802887

[71] Koh AS,Gao F.Left atrial phasic function in older adults is associated with fibrotic and low-grade inflammatory pathways.Gerontology2023;69:47-56 PMCID:PMC9492896

[72] Li D,Leung TK.Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort.Circulation1999;100:87-95

[73] Hopman LHGA,van der Laan AM.Impaired left atrial reservoir and conduit strain in patients with atrial fibrillation and extensive left atrial fibrosis.J Cardiovasc Magn Reson2021;23:131

[74] Forsey RJ,Ernerudh J.Plasma cytokine profiles in elderly humans.Mech Ageing Dev2003;124:487-93

[75] Bonnema DD,Pennington WR.Effects of age on plasma matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs).J Card Fail2007;13:530-40 PMCID:PMC2698433

[76] Polejaeva IA,Davies CJ.Increased susceptibility to atrial fibrillation secondary to atrial fibrosis in transgenic goats expressing transforming growth factor-β1.J Cardiovasc Electrophysiol2016;27:1220-9 PMCID:PMC5065395

[77] Guzadhur L,Duehmke RM.Atrial arrhythmogenicity in aged Scn5a⁺/DeltaKPQ mice modeling long QT type 3 syndrome and its relationship to Na⁺ channel expression and cardiac conduction.Pflugers Arch2010;460:593-601 PMCID:PMC2903684

[78] Baba S,Hirose M.Sodium current function in adult and aged canine atrial cells.Am J Physiol Heart Circ Physiol2006;291:H756-61

[79] Dun W,Rosen MR.Calcium and potassium currents in cells from adult and aged canine right atria.Cardiovasc Res2003;58:526-34

[80] Nagibin V,Viczenczova C.Ageing related down-regulation of myocardial connexin-43 and up-regulation of MMP-2 may predict propensity to atrial fibrillation in experimental animals.Physiol Res2016;65 Suppl 1:S91-S100

[81] Di Micco R, Krizhanovsky V, Baker D, d'Adda di Fagagna F. Cellular senescence in ageing: from mechanisms to therapeutic opportunities.Nat Rev Mol Cell Biol2021;22:75-95 PMCID:PMC8344376

[82] He S.Senescence in health and disease.Cell2017;169:1000-11 PMCID:PMC5643029

[83] Hu C,Teng T,Tang QZ.Cellular senescence in cardiovascular diseases: a systematic review.Aging Dis2022;13:103-28 PMCID:PMC8782554

[84] Jesel L,Park SH.Atrial fibrillation progression is associated with cell senescence burden as determined by p53 and p16 expression.J Clin Med2019;9:36 PMCID:PMC7019631

[85] Tang X,Chen HZ.Cardiomyocyte senescence and cellular communications within myocardial microenvironments.Front Endocrinol2020;11:280 PMCID:PMC7253644

[86] Anderson R,Maggiorani D.Length-independent telomere damage drives post-mitotic cardiomyocyte senescence.EMBO J2019;38:e100492

[87] Gao XY,Luo XS.Acetyltransferase p300 regulates atrial fibroblast senescence and age-related atrial fibrosis through p53/Smad3 axis.Aging Cell2023;22:e13743 PMCID:PMC9835568

[88] Hasan H,Auger C.Thrombin induces angiotensin II-mediated senescence in atrial endothelial cells: impact on pro-remodeling patterns.J Clin Med2019;8:1570 PMCID:PMC6833093

[89] Sen P,Nativio R.Epigenetic mechanisms of longevity and aging.Cell2016;166:822-39 PMCID:PMC5821249

[90] Herman AB,Sen P.Epigenetic dysregulation in cardiovascular aging and disease.J Cardiovasc Aging2021;1:10 PMCID:PMC8594871

[91] Roberts JD,Lu AT.Epigenetic age and the risk of incident atrial fibrillation.Circulation2021;144:1899-911 PMCID:PMC8671333

[92] Lin H,Xie Z.Methylome-wide association study of atrial fibrillation in Framingham heart study.Sci Rep2017;7:40377 PMCID:PMC5220313

[93] Doñate Puertas R,Romestaing C.Atrial fibrillation is associated with hypermethylation in human left atrium, and treatment with decitabine reduces atrial tachyarrhythmias in spontaneously hypertensive rats.Transl Res2017;184:57-67.e5

[94] Lugenbiel P,Syren P.Epigenetic regulation of cardiac electrophysiology in atrial fibrillation: HDAC2 determines action potential duration and suppresses NRSF in cardiomyocytes.Basic Res Cardiol2021;116:13

[95] Song S,Mo B.EZH2 as a novel therapeutic target for atrial fibrosis and atrial fibrillation.J Mol Cell Cardiol2019;135:119-33

[96] Jusic A,Wettinger SB.Noncoding RNAs in age-related cardiovascular diseases.Ageing Res Rev2022;77:101610

[97] Varghese LN,Katare R.Role of noncoding RNAs in cardiac ageing.Front Cardiovasc Med2023;10:1142575 PMCID:PMC10073704

[98] Jazbutyte V,Kneitz S.MicroRNA-22 increases senescence and activates cardiac fibroblasts in the aging heart.Age2013;35:747-62 PMCID:PMC3636396

[99] Boon RA,Lechner S.MicroRNA-34a regulates cardiac ageing and function.Nature2013;495:107-10

[100] Trembinski DJ,Theodorou K.Aging-regulated anti-apoptotic long non-coding RNA Sarrah augments recovery from acute myocardial infarction.Nat Commun2020;11:2039 PMCID:PMC7184724

[101] Adam O,Thum T.Role of miR-21 in the pathogenesis of atrial fibrosis.Basic Res Cardiol2012;107:278

[102] Lu Y,Wang N.MicroRNA-328 contributes to adverse electrical remodeling in atrial fibrillation.Circulation2010;122:2378-87

[103] Luo X,Shan H.MicroRNA-26 governs profibrillatory inward-rectifier potassium current changes in atrial fibrillation.J Clin Invest2013;123:1939-51 PMCID:PMC3635715

[104] Benjamin EJ,Vaziri SM,Belanger AJ.Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study.JAMA1994;271:840-4

[105] Vieira MJ,Gonçalves L.Left atrial mechanics: echocardiographic assessment and clinical implications.J Am Soc Echocardiogr2014;27:463-78

[106] Lisi M,Cameli M.Left atrial strain by speckle tracking predicts atrial fibrosis in patients undergoing heart transplantation.Eur Heart J Cardiovasc Imaging2022;23:829-35

[107] Patel DA,Milani RV,Gilliland Y.Clinical implications of left atrial enlargement: a review.Ochsner J2009;9:191-6 PMCID:PMC3096293

[108] Kuppahally SS,Burgon NS.Left atrial strain and strain rate in patients with paroxysmal and persistent atrial fibrillation: relationship to left atrial structural remodeling detected by delayed-enhancement MRI.Circ Cardiovasc Imaging2010;3:231-9

[109] Olsen FJ,Jørgensen PG.Left atrial strain predicts subclinical atrial fibrillation detected by long-term continuous monitoring in elderly high-risk individuals.Circ Cardiovasc Imaging2024;17:e016197

[110] Mannina C,Jin Z.Association of left atrial strain with ischemic stroke risk in older adults.JAMA Cardiol2023;8:317-25 PMCID:PMC9909576

[111] Maffeis C,Cannata L.Left atrial strain predicts exercise capacity in heart failure independently of left ventricular ejection fraction.ESC Heart Fail2022;9:842-52 PMCID:PMC8934969

[112] Jia F,Zhang D,Chen W.Prognostic value of left atrial strain in heart failure: a systematic review and meta-analysis.Front Cardiovasc Med2022;9:935103 PMCID:PMC9283726

[113] Donal E,Schnell F.Left atrial strain: a must or a plus for routine clinical practice?.Circ Cardiovasc Imaging2017;10:e007023

[114] Badano LP,Muraru D.Standardization of left atrial, right ventricular, and right atrial deformation imaging using two-dimensional speckle tracking echocardiography: a consensus document of the EACVI/ASE/Industry Task Force to standardize deformation imaging.Eur Heart J Cardiovasc Imaging2018;19:591-600

[115] Pathan F,Nolan MT,Negishi K.Normal ranges of left atrial strain by speckle-tracking echocardiography: a systematic review and meta-analysis.J Am Soc Echocardiogr2017;30:59-70.e8

[116] Yuda S,Isobe F,Miyatake K.Comparative efficacy of the maze procedure for restoration of atrial contraction in patients with and without giant left atrium associated with mitral valve disease.J Am Coll Cardiol1998;31:1097-102

[117] Vasan RS,Levy D,Wolf PA.National HeartLungand Blood InstituteNational Institutes of HealthDoppler transmitral flow indexes and risk of atrial fibrillation (the Framingham Heart Study).Am J Cardiol2003;91:1079-83

[118] Thomas L,Popescu BA.Evaluation of left atrial size and function: relevance for clinical practice.J Am Soc Echocardiogr2020;33:934-52

[119] Khankirawatana B,Peterson B,Porter TR.Peak atrial systolic mitral annular velocity by Doppler tissue reliably predicts left atrial systolic function.J Am Soc Echocardiogr2004;17:353-60

[120] Siebermair J,Marrouche N.Assessment of left atrial fibrosis by late gadolinium enhancement magnetic resonance imaging: methodology and clinical implications.JACC Clin Electrophysiol2017;3:791-802

[121] Whitaker J,Karim R.Standardised computed tomographic assessment of left atrial morphology and tissue thickness in humans.Int J Cardiol Heart Vasc2021;32:100694 PMCID:PMC7772783

[122] Romero J,Kelesidis I,Medina HM.Detection of left atrial appendage thrombus by cardiac computed tomography in patients with atrial fibrillation: a meta-analysis.Circ Cardiovasc Imaging2013;6:185-94

[123] Patel RB,Sun JL.Biomarker profile of left atrial myopathy in heart failure with preserved ejection fraction: insights from the RELAX trial.J Card Fail2020;26:270-5 PMCID:PMC7078046

[124] Guo J,Dou L.Aging and aging-related diseases: from molecular mechanisms to interventions and treatments.Signal Transduct Target Ther2022;7:391 PMCID:PMC9755275

[125] Barnett K,Norbury M,Wyke S.Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study.Lancet2012;380:37-43

[126] Rivner H,Goldberger JJ.Atrial myopathy underlying atrial fibrillation.Arrhythm Electrophysiol Rev2020;9:61-70 PMCID:PMC7491052

[127] Kallergis EM,Vardas PE.Atrial fibrillation: a progressive atrial myopathy or a distinct disease?.Int J Cardiol2014;171:126-33

[128] Kornej J,Benjamin EJ.Epidemiology of Atrial fibrillation in the 21st century: novel methods and new insights.Circ Res2020;127:4-20 PMCID:PMC7577553

[129] Khurshid S,Ellinor PT.Prevalence and incidence of atrial fibrillation among older primary care patients.JAMA Netw Open2023;6:e2255838 PMCID:PMC11015386

[130] Granada J,Chyou PH.Incidence and predictors of atrial flutter in the general population.J Am Coll Cardiol2000;36:2242-6

[131] Waldo AL.Inter-relationships between atrial flutter and atrial fibrillation.Pacing Clin Electrophysiol2003;26:1583-96

[132] Wolf PA,Thomas HE Jr.Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study.Neurology1978;28:973-7

[133] Odutayo A,Hsiao AJ,Altman DG.Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis.BMJ2016;354:i4482

[134] Benjamin EJ,D'Agostino RB,Kannel WB.Impact of atrial fibrillation on the risk of death: the Framingham Heart Study.Circulation1998;98:946-52

[135] Redfield MM.Heart failure with preserved ejection fraction: a review.JAMA2023;329:827-38

[136] Melenovsky V,Redfield MM,Lin G.Left atrial remodeling and function in advanced heart failure with preserved or reduced ejection fraction.Circ Heart Fail2015;8:295-303

[137] Patel RB,Svedlund S.Disproportionate left atrial myopathy in heart failure with preserved ejection fraction among participants of the PROMIS-HFpEF study.Sci Rep2021;11:4885 PMCID:PMC7921666

[138] Tamargo M,Reddy YNV.Functional mitral regurgitation and left atrial myopathy in heart failure with preserved ejection fraction.Eur J Heart Fail2020;22:489-98

[139] Deedwania PC.Atrial fibrillation in heart failure: a comprehensive review.Am J Med2010;123:198-204

[140] Smietana J,Halperin JL.Thromboembolism in the absence of atrial fibrillation.Am J Cardiol2019;124:303-11

[141] Brambatti M,Gold MR.Temporal relationship between subclinical atrial fibrillation and embolic events.Circulation2014;129:2094-9

[142] Souza JB,Laurinavicius AG.Advanced echocardiography techniques (AETs) to assess left atrial structure and function in individuals with resistant hypertension.Echocardiography2023;40:792-801

[143] Vera A,Ximénez-Carrillo Á.Advanced echocardiography with left atrial strain and indexed left atrial three-dimensional volume for predicting underlying atrial fibrillation after cryptogenic stroke.Am J Cardiol2022;185:87-93

[144] Peters DC,Sinusas AJ.Left atrial evaluation by cardiovascular magnetic resonance: sensitive and unique biomarkers.Eur Heart J Cardiovasc Imaging2021;23:14-30 PMCID:PMC8685602

[145] Pay L,Satti DI.Arrhythmias beyond atrial fibrillation detection using smartwatches: a systematic review.Anatol J Cardiol2023;27:126-31 PMCID:PMC9995551

[146] Mannhart D,Knecht S.Clinical validation of 5 direct-to-consumer wearable smart devices to detect atrial fibrillation: BASEL wearable study.JACC Clin Electrophysiol2023;9:232-42

[147] Verbrugge FH,Attia ZI.Detection of left atrial myopathy using artificial intelligence-enabled electrocardiography.Circ Heart Fail2022;15:e008176 PMCID:PMC8766932

[148] Yuan N,Duffy G.Deep learning evaluation of echocardiograms to identify occult atrial fibrillation.NPJ Digit Med2024;7:96 PMCID:PMC11016113

[149] Aquino GJ,Yacoub B.Diagnostic accuracy and performance of artificial intelligence in measuring left atrial volumes and function on multiphasic CT in patients with atrial fibrillation.Eur Radiol2022;32:5256-64

[150] Pieszko K,Łojewska K.Artificial intelligence in detecting left atrial appendage thrombus by transthoracic echocardiography and clinical features: the Left Atrial Thrombus on Transoesophageal Echocardiography (LATTEE) registry.Eur Heart J2024;45:32-41 PMCID:PMC10757867

[151] Oakes RS,Kholmovski EG.Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation.Circulation2009;119:1758-67 PMCID:PMC2725019

[152] Marrouche NF,Hindricks G.Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study.JAMA2014;311:498-506

[153] Marrouche NF,McGann C.Effect of MRI-guided fibrosis ablation vs conventional catheter ablation on atrial arrhythmia recurrence in patients with persistent atrial fibrillation: The DECAAF II randomized clinical trial.JAMA2022;327:2296-305

[154] Takemoto Y,Seward JB.Usefulness of left atrial volume in predicting first congestive heart failure in patients > 65 years of age with well-preserved left ventricular systolic function.Am J Cardiol2005;96:832-6

[155] Osranek M,Qaddoura F.Left atrial volume predicts the risk of atrial fibrillation after cardiac surgery: a prospective study.J Am Coll Cardiol2006;48:779-86

[156] Beinart R,Schwammenthal E.Long-term prognostic significance of left atrial volume in acute myocardial infarction.J Am Coll Cardiol2004;44:327-34

[157] Thadani SR,Fang Q,Schiller NB.Left atrial end-diastolic volume index as a predictor of cardiovascular outcomes: the heart and soul study.Circ Cardiovasc Imaging2020;13:e009746 PMCID:PMC8846436

[158] Shin SH,Inciardi RM.Prognostic value of minimal left atrial volume in heart failure with preserved ejection fraction.J Am Heart Assoc2021;10:e019545 PMCID:PMC8475710

[159] Kreimer F.Left atrial cardiomyopathy - a challenging diagnosis.Front Cardiovasc Med2022;9:942385 PMCID:PMC9280085

[160] Olsen FJ,de Knegt MC.Multimodality cardiac imaging for the assessment of left atrial function and the association with atrial arrhythmias.Circ Cardiovasc Imaging2016;9:e004947

[161] Babuin L.Troponin: the biomarker of choice for the detection of cardiac injury.Can Med Assoc J2005;173:1191-202

[162] Mueller C,de Boer RA.Heart failure association of the european society of cardiology practical guidance on the use of natriuretic peptide concentrations.Eur J Heart Fail2019;21:715-31

[163] Kennedy JW,Murray JA.Quantitative angiocardiography. IV. Relationships of left atrial and ventricular pressure and volume in mitral valve disease.Circulation1970;41:817-24

[164] Zile MR,Hetzel SJ.Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction.Circulation2011;124:2491-501

[165] Rienstra M,Alings M.Targeted therapy of underlying conditions improves sinus rhythm maintenance in patients with persistent atrial fibrillation: results of the RACE 3 trial.Eur Heart J2018;39:2987-96

[166] Patel RB.Therapeutic targeting of left atrial myopathy in atrial fibrillation and heart failure with preserved ejection fraction.JAMA Cardiol2020;5:497-9 PMCID:PMC7529338

[167] Milliez P,Rucker-Martin C.Spironolactone reduces fibrosis of dilated atria during heart failure in rats with myocardial infarction.Eur Heart J2005;26:2193-9

[168] Shantsila E,Sun Y.Spironolactone in atrial fibrillation with preserved cardiac fraction: the IMPRESS-AF trial.J Am Heart Assoc2020;9:e016239 PMCID:PMC7726985

[169] Feldman T,Kahwash R.Transcatheter interatrial shunt device for the treatment of heart failure with preserved ejection fraction (REDUCE LAP-HF I [reduce elevated left atrial pressure in patients with heart failure]): a phase 2, randomized, sham-controlled trial.Circulation2018;137:364-75

[170] Simard T,Zahr F.Percutaneous atriotomy for levoatrial-to-coronary sinus shunting in symptomatic heart failure: first-in-human experience.JACC Cardiovasc Interv2020;13:1236-47

[171] Voors AA,Cleland JG.Effects of danicamtiv, a novel cardiac myosin activator, in heart failure with reduced ejection fraction: experimental data and clinical results from a phase 2a trial.Eur J Heart Fail2020;22:1649-58 PMCID:PMC7689751

[172] Kumar M,Kuchel GA.Cellular senescence as a targetable risk factor for cardiovascular diseases: therapeutic implications: JACC family series.JACC Basic Transl Sci2024;9:522-34 PMCID:PMC11055207

[173] Marcoux E,Ninni S.Genetic atrial cardiomyopathies: common features, specific differences, and broader relevance to understanding atrial cardiomyopathy.Circ Arrhythm Electrophysiol2023;16:675-98

[174] Roselli C,Ellinor PT.Genetics of atrial fibrillation in 2020: GWAS, genome sequencing, polygenic risk, and beyond.Circ Res2020;127:21-33 PMCID:PMC7388073

[175] Hart RG,Perera KS,Connolly SJ.Embolic stroke of undetermined source: a systematic review and clinical update.Stroke2017;48:867-72

[176] Kamel H,Tirschwell DL.Apixaban to prevent recurrence after cryptogenic stroke in patients with atrial cardiopathy: the ARCADIA randomized clinical trial.JAMA2024;331:573-81

[177] Marcus GM.Anticoagulation for atrial cardiopathy in cryptogenic stroke.JAMA2024;331:564-6

[178] Chi KY,Nanna MG.Apixaban to prevent recurrence after cryptogenic stroke.JAMA2024;331:1965-6

[179] Rigatelli G.Apixaban to prevent recurrence after cryptogenic stroke.JAMA2024;331:1966